7 | Peptides (Polypeptides)IBA
09/2014
-
04/2005 |
5 | Pharmaceutical PreparationsIBA
04/2013
-
10/2008 |
4 | Liposomes (Liposome)IBA
01/2021
-
11/2013 |
3 | Hydrogen Sulfide (Sulfide, Hydrogen)IBA
10/2022
-
11/2017 |
3 | Immunoglobulin G (IgG)IBA
08/2017
-
03/2009 |
3 | Radioisotopes (Radionuclides)IBA
12/2010
-
04/2005 |
2 | CopperIBA
01/2019
-
11/2018 |
2 | Collagen Type II (Type II Collagen)IBA
08/2017
-
01/2016 |
2 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2017
-
01/2016 |
2 | cysteinyl- glutaminyl- arginyl- prolyl- prolyl- arginineIBA
01/2015
-
12/2010 |
2 | GoldIBA
11/2013
-
04/2013 |
2 | Trastuzumab (Herceptin)FDA Link
08/2013
-
04/2011 |
2 | sodium-iodide symporter (sodium iodide symporter)IBA
01/2011
-
09/2008 |
2 | Fluorescein (Funduscein)FDA LinkGeneric
11/2008
-
10/2008 |
1 | Folic Acid (Vitamin M)FDA LinkGeneric
11/2021 |
1 | EsterasesIBA
11/2021 |
1 | Contrast MediaIBA
01/2021 |
1 | Polyethylene (Polythene)IBA
12/2020 |
1 | nido-carboraneIBA
12/2020 |
1 | BoronIBA
12/2020 |
1 | Oxygen (Dioxygen)IBA
01/2019 |
1 | 1- myristoyl- 2- (12- ((5- dimethylamino- 1- naphthalenesulfonyl)amino)dodecanoyl)- sn- glycero- 3- phosphocholineIBA
01/2019 |
1 | arginyl-glycyl-aspartic acidIBA
11/2018 |
1 | ethyleneIBA
11/2018 |
1 | Chelating AgentsIBA
11/2018 |
1 | propylene (propene)IBA
11/2018 |
1 | LipidsIBA
11/2017 |
1 | CystathionineIBA
11/2017 |
1 | Proteins (Proteins, Gene)FDA Link
11/2017 |
1 | DNA (Deoxyribonucleic Acid)IBA
11/2017 |
1 | AntioxidantsIBA
11/2017 |
1 | LyasesIBA
11/2017 |
1 | Superoxides (Superoxide)IBA
11/2017 |
1 | TriterpenesIBA
08/2017 |
1 | Ursolic AcidIBA
08/2017 |
1 | EnzymesIBA
01/2016 |
1 | Acetates (Acetic Acid Esters)FDA Link
01/2016 |
1 | Oleanolic AcidIBA
01/2016 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
01/2015 |
1 | Annexin A5IBA
01/2015 |
1 | 1,8- N,N'- bis- (carboxymethyl)- 4- N''- (4'- isothiocyanatophenethyl)- 1,4,8,11- tetraazacyclotetradecaneIBA
08/2013 |
1 | Biomarkers (Surrogate Marker)IBA
03/2013 |
1 | Dextrans (Dextran)FDA Link
03/2013 |
1 | IntegrinsIBA
02/2013 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
02/2013 |
1 | GadoliniumIBA
02/2013 |
1 | Tyrosine (L-Tyrosine)FDA Link
07/2012 |
1 | RadiopharmaceuticalsIBA
07/2012 |
1 | IodineIBA
07/2012 |
1 | DisulfidesIBA
07/2012 |
1 | Technetium Tc 99m Dimercaptosuccinic AcidIBA
03/2011 |
1 | Histones (Histone)IBA
12/2010 |
1 | Fluorescent Dyes (Fluorescent Probes)IBA
12/2010 |
1 | Fluorouracil (Carac)FDA LinkGeneric
04/2009 |
1 | FlavonoidsIBA
04/2009 |
1 | Hypnotics and Sedatives (Sedatives)IBA
04/2009 |
1 | ApigeninIBA
04/2009 |
1 | Diazepam (Valium)FDA LinkGeneric
04/2009 |
1 | Immunoglobulin FragmentsIBA
03/2009 |
1 | Monoclonal AntibodiesIBA
03/2009 |
1 | LDL Receptors (LDL Receptor)IBA
10/2008 |
1 | LigandsIBA
10/2008 |
1 | Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
10/2008 |
1 | Estrogen Receptor alphaIBA
10/2005 |
1 | Estrogen Receptor betaIBA
10/2005 |
1 | Hormones (Hormone)IBA
10/2005 |
1 | 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA
04/2005 |
1 | alpha-MSHIBA
04/2005 |